Survivin expression in colorectal: real time polymerase chain reaction and correlation with clinicopathological features
Colorectal cancer develops in a multi-step process and is associated with genetic alterations. Blocking apoptosis is a key factor to unlimited cell proliferation and immortalization. Survivin expression inhibits the programmed cell death process, apoptosis. This molecule could play a potential rol...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Penerbit Universiti Kebangsaan Malaysia
2014
|
| Online Access: | http://journalarticle.ukm.my/8677/1/43_2_05.pdf http://journalarticle.ukm.my/8677/ http://mabjournal.com/index.php?option=com_content&view=article&id=460&catid=59:current-view&Itemid=56 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universiti Kebangsaan Malaysia |
| Language: | English |
| Summary: | Colorectal cancer develops in a multi-step process and is associated with genetic alterations. Blocking apoptosis is a key
factor to unlimited cell proliferation and immortalization. Survivin expression inhibits the programmed cell death process,
apoptosis. This molecule could play a potential role in cancer development. Survivin is an attractive target for clinical trials to
develop cancer treatment. RNA was prepared from colorectal tumor and adjacent non-tumor tissues and then transcribed to
complementary DNA. Human survivin mRNA levels were quantitatively measured by real time polymerase chain reaction
(PCR) in tumor and adjacent non-tumor tissues. Expression levels of survivin mRNA in adenocarcinomas were significantly
higher than in non-tumor mucosa (p < 0.0001). The expressions of survivin mRNA in adenocarcinomas were related to the
degree of differentiation (survivin; p=0.034). No difference was found with other clinicopathological features. These findings
indicate survivin role in colorectal carcinogenesis. Survivin could be used as a potential diagnostic and prognostic marker in
colorectal cancer. Successful inhibition of this molecule could lead to the development of a new drug for cancer therapy. |
|---|